Top Markets
Coin of the day
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation

InVivo Therapeutics Holdings Corporation

NVIV
Rang in aandelen #39770
InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm,... InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI). Its primary investigational product is the Neuro-Spinal Scaffold implant, a bioresorbable polymer scaffold. This device is engineered to be implanted directly at the site of injury within the spinal cord, aiming to treat acute SCI. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.
Aandeelprijs
$0.26
Laatst gesynchroniseerd: 2024-03-11
Marktkapitalisatie
$356.29K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel InVivo Therapeutics Holdings Corporation (NVIV)

Categorie

Dividendrendementgeschiedenis voor InVivo Therapeutics Holdings Corporation (NVIV)
Het dividendrendement (TTM) van InVivo Therapeutics Holdings Corporation (aandelsymbool: NVIV) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van InVivo Therapeutics Holdings Corporation (NVIV) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten